| 2025 | Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma | Jedd D Wolchok | PMC12080919 | https://pubmed.ncbi.nlm.nih.gov/39282897/ | 0 |
| 2025 | Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up. | Sato R | PMC11910964 | https://europepmc.org/article/pmc/pmc11910964 | 0 |
| 2026 | Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial | T K Choueiri | 41786248 | https://pubmed.ncbi.nlm.nih.gov/41786248/ | 0 |
| 2025 | Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial | Thierry André | 39874977 | https://pubmed.ncbi.nlm.nih.gov/39874977/ | 0 |